712 North Inc. is a preclinical biotechnology company developing first-in-class small molecules to treat aging-related diseases, including cancer and neurodegeneration.
We operate as a fully autonomous virtual entity to deploy 100% of capital directly into R&D through a software-defined, computer-assisted business model that delivers unmatched agility and decision velocity.
